Tag: Kidney Disease
-
Sobi to Unveil One-Year Pegcetacoplan Data for C3G, IC-MPGN and NASP at ASN Kidney Week 2025
Overview: Sobi to Share New Pegcetacoplan Data at ASN Kidney Week 2025 Sobi, a global biopharmaceutical company focused on rare diseases, has announced that new data on pegcetacoplan will be presented at ASN Kidney Week 2025, taking place from November 5–9. The presentations will explore one-year efficacy data for pegcetacoplan in C3 glomerulopathy (C3G) and…
-
SDMA as a Predictor of Cardiovascular Risk in CKD Patients
New findings reshape how we view blood markers in CKD and cardiovascular risk When researchers at the University of Texas at Arlington set out to understand why people with chronic kidney disease (CKD) often die from heart problems rather than kidney failure, they revisited a long-standing assumption about blood markers. For years, scientists highlighted ADMA…
-
Inactive SDMA Emerges as Potential Predictor of Cardiovascular Risk in CKD
New Findings Reframe SDMA’s Role in CKD-Related Cardiovascular Risk When researchers at the University of Texas at Arlington set out to understand why people with chronic kidney disease (CKD) are at heightened risk for heart problems, they revisited a long-standing assumption. For years, ADMA—asymmetric dimethylarginine—has been considered a warning sign for vascular dysfunction. But a…
-
New Research Unveils Hidden Code in Kidney Diseases
Recent findings from an international team of researchers, spearheaded by the University of Sichuan, delve into the complexities of kidney health by unveiling a ‘hidden code’ linked to the development of kidney diseases. Published in *Precision Clinical Medicine*, this groundbreaking study elucidates how alterations in the glycosylation of proteins can significantly impact renal health, providing…